Showing results (201-210 of 3,716) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|May 30, 2020
Ubiquitin-specific protease 7 is a druggable target that is essential for pancreatic cancer growth and chemoresistanceHao Chen, Xiaoling Zhu, Rong Sun, et al.
Investigational New Drugs|June 20, 2020
Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumorsJennifer R Eads, Smitha S Krishnamurthi, Joel Saltzman, et al.
Investigational New Drugs|June 22, 2020
The safety and tolerability of epacadostat alone and in combination with pembrolizumab in patients with advanced solid tumors: results from a first-in-Japanese phase I study (KEYNOTE-434)Toshihiko Doi, Yutaka Fujiwara, Kohei Shitara, et al.
Investigational New Drugs|September 13, 2021
A comprehensive analysis of different gene classes in pancreatic cancer: SIGLEC15 may be a promising immunotherapeutic targetJi-Li Xu, Yong Guo
Investigational New Drugs|April 1, 1992
An efficient multiple-exposure analysis of the toxicity of crisnatol, a DNA intercalator in phase II clinical trialsR M Zucker, D J Adams, K W Bair, et al.
Investigational New Drugs|October 6, 2005
Phase II study of interferon-alpha and doxycycline for advanced renal cell carcinomaMichael Huie, Kurt Oettel, Lynn Van Ummersen, et al.
Investigational New Drugs|March 4, 2005
A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancerJohn Murren, Manuel Modiano, Shivaani Kummar, et al.
Investigational New Drugs|March 4, 2005
Prolonged infusion of gemcitabine in advanced solid tumors: a phase-I-studyPeter Schmid, Marcus Schweigert, Thomas Beinert, et al.
Investigational New Drugs|April 1, 1992
Trimetrexate in advanced renal cell carcinoma. An ECOG phase II trialR S Witte, P Elson, G T Bryan, et al.
Investigational New Drugs|September 30, 2005
A phase I/II study of docetaxel, etoposide, and carboplatin before concurrent chemoradiotherapy with cisplatin and etoposide in limited-stage small cell lung cancerPatrapim Sunpaweravong, Lyn Magree, Rachel Rabinovitch, et al.
Pageof 372